Inactive Instrument

Islet Sciences Inc Stock OTC Bulletin Board

Equities

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

Islet Sciences, Inc. Publishes Data Supporting Remogliflozin Etabonate as a Potential Treatment for NAFLD and NASH	15-05-04	GL
Islet Sciences, Inc. Presented at 50th International Liver Conference	15-04-23	GL
Islet Sciences, Inc. COO to Present at Metabolic Leaders Forum	15-03-24	GL
Islet Sciences, Inc. COO to Present at EASL: Remogliflozin Etabonate as Novel Treatment for Non-alcoholic Steatohepatitis (NASH)	15-03-09	GL
Islet Sciences, Inc. Confirms Issuance of U.S. Patent for Using SGLT2 Inhibitors to Treat NASH/NAFLD	15-03-05	GL

Sector

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+4.09%	43.84B
LONZA GROUP AG	+46.85%	41.25B
MODERNA, INC.	+9.45%	41.68B
CELLTRION, INC.	-10.92%	27.04B
ICON PUBLIC LIMITED COMPANY	+9.32%	25.53B
ALNYLAM PHARMACEUTICALS, INC.	-24.87%	18.18B
MEDPACE HOLDINGS, INC.	+29.70%	12.29B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.28%	12.29B
UNITED THERAPEUTICS CORPORATION	+7.78%	11.15B